The Department participates in multi-national clinical trials for new agents in the management of IBD. For more details, please see our Clinical Trials page.

• POCER Study: Causes and treatment of recurrent Crohn’s disease after bowel resection.
• GECCO Study: Incidence, prevalence, and natural history of IBD in the Barwon district.
• STRIDENT Study: Optimal management of strictures in Crohn’s disease.
• PICCOLO Study: Outcomes of mothers and babies born to mothers with IBD.
• ENIGMA Study: Gut microbiome in IBD.
• PREDICT-UC Study: Management of acute severe ulcerative colitis.
• South East Asia and Australia Study: Differences in IBD prevalence and natural history.
• Faecal Transplantation Study: Potential to alter the natural history of ulcerative colitis.
• PROMISE and PRO-PROMISE Studies: Various IBD research projects.
• PROVOCATIVE Study: Various IBD research projects.
• MIRO Study: Faecal microbial transplantation in Crohn’s Disease.
• Early Therapy Optimisation Study: Medical and surgical therapies for fistula-in-ano.
• DELECTABLE Study: Tolerability and adherence to dietary therapy in IBD.

The Inflammatory Bowel Disease (IBD) Research Program is dedicated to advancing innovative techniques for diagnosing and treating IBD. Our research focuses on improving patient outcomes and transforming clinical practices for conditions like Crohn’s disease and ulcerative colitis. Stay tuned for upcoming publications that will showcase the impact of our ongoing work in the field of IBD.

For research fellowship opportunities and collaborative projects, please contact Prof Michael Kamm, A/Prof William Connell, A/Prof Nik John Ding, or Dr Emily Wright.